2024 Atai stocks - Mar 31, 2023 · Atai Life Sciences ( ATAI 2.80%), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of ...

 
Validation of atai's operating model and ability to capture value: IPO of COMPASS Pathways in 2020 and licensing deal between Otsuka and atai subsidiary Perception Neuroscience in 2021 Strong cash position of approx. $273M (as of December 31 st , 2022) and access to up to an additional $160m from term loan facility with Hercules 2 lead to .... Atai stocks

ATAI Life Sciences N.V. Watch Set a price target alert Premarket Last Updated: Nov 15, 2023 8:18 a.m. EST Delayed quote $ 1.2900 0.04 2.79% Before Hours Volume: 2.23K …atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights. Phase 2b study of RL-007 in CIAS patients continues to be on track to report data in 2H 2024 and data from the EMP-01 (MDMA derivative) Phase 1 study is anticipated to report out later this year. Phase 1 data of VLS-01 (a proprietary oral transmucosal film ...ATAI Life Sciences-stock ATAI Life Sciences N.V. Registered Shs Stock , ATAI 1.14 +0.04 +3.64% After-market 04:50:40 PM EDT 11/24/2023 NAS Add to …From July 11 to July 14, the ARK Genomic Revolution ETF (BATS: ARKG) purchased 674,424 shares of ATAI stock. The company is now the 45th-largest holding in the ETF out of 48 total.The comedown has also put a dent in Angermayer’s wealth. Adjusting for its cash, investors now value Atai’s drug pipeline at $470 million. Nearly $1.8 billion was raised by psychedelics ...WebIn 2019 ATAI had a net loss of $24,384,000. They had basically no income (as would be expected from any nascent company developing new drugs). Roughly $3 million was spent on R&D, almost $10 million on acquiring programs, and $5 million on general/administrative expenses. In 2020 ATAI has a net loss of $178,000,000.The stock has given up three-quarters of its market value year to date. Ark Genomic bought 67,384 shares of Atai Life Sciences - Get Free Report, valued at $284,360. Atai is a Berlin ...The average trading volume of ATAI on November 29, 2023 was 536.92K shares. ATAI) stock’s latest price update. The stock price of ATAI Life Sciences N.V. (NASDAQ: ATAI) has plunged by -3.51 when compared to previous closing price of 1.14, but the company has seen a 2.80% gain in its stock price over the last five trading sessions.Get ATAI Life Sciences NV (ATAI.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsView the latest ATAI Life Sciences N.V. (ATAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.Find the latest Atari SA (ALATA.PA) stock quote, history, news and other vital information to help you with your stock trading and investing.Even in a speculative industry, I believe the stock is undervalued by these few facts alone. ATAI holds: 450M cash and cash equivalents; 20% equity stake in CMPS (750M mktcp - 150M worth at current prices); and ATAI has a vast ip pipeline that includes 9 lead compounds. Curious as to the community’s thoughts here!Discover historical prices for ATAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Atai Life Sciences N.V. stock was issued.Atai Life Sciences has a strong pipeline of drugs for the next 18 months, and will pursue aggressive growth. The company had $335 million in cash as of May 2022, which is roughly 50% of its ...Find the latest Atari SA (PONGF) stock quote, history, news and other vital information to help you with your stock trading and investing.Atai Life Sciences ( ATAI 2.80%), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of ...Atai Life Sciences Announces Results from the Phase 1 Iv-To-Subcutaneous Bridging Study of Pcn-101 (R-Ketamine) Aug. 08: CI Atai Life Sciences N.V., Atai Life Sciences AG Enters into the Second Amendment to Loan and Security Agreement with the Several Banks May. 31: CIIn 2019 ATAI had a net loss of $24,384,000. They had basically no income (as would be expected from any nascent company developing new drugs). Roughly $3 million was spent on R&D, almost $10 million on acquiring programs, and $5 million on general/administrative expenses. In 2020 ATAI has a net loss of $178,000,000. Nov 3, 2023 · ATAI Life Sciences NV (ATAI) stock is trading at $1.33 as of 10:11 AM on Friday, Nov 3, an increase of $0.09, or 7.31% from the previous closing price of $1.24. The stock has traded between $1.20 and $1.34 so far today. Volume today is low. So far 138,480 shares have traded compared to average volume of 503,480 shares. Mind Medicine Inc. ( MNMD) MindMed shares are down by 38.7% over the past three months, but they are up 23.2% year to date as of Oct. 24. The New York-based company specializes in the development ...ATAI Life Sciences N.V. Common Shares (ATAI) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Live Key Data Bid Price and Ask Price The bid & ask refers to the price... atai Life Sciences N.V. - Buy. Zacks' proprietary data indicates that atai Life Sciences N.V. is currently rated as a Zacks Rank 2 and we are expecting an above average return from the ATAI shares ...RPHM. Reneo Pharmaceuticals Inc. 6.04. +0.10. +1.68%. Get ATAI Life Sciences NV (ATAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Florian Brand's Atai Life Sciences went public three years after launching, fueled by Silicon Valley interest and promising science, but it's still waiting for its first big breakthrough.N/A. 1. Capital is getting (a lot) harder to come by. Perhaps the most frustrating trend for investors considering psychedelic stocks is the rising cost of borrowing money. As inflation surges in ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Atai Life Sciences has a strong financial position with $227.5 million in cash and funding to support its operations into the 1st half of 2026. The global schizophrenia drug market is expected to ...Atai Capital highlighted stocks like Alphabet Inc. (NASDAQ:GOOG) in the Q3 2023 investor letter. Headquartered in Mountain View, California, Alphabet Inc. …Find real-time ATAI - ATAI Life Sciences NV stock quotes, company profile, news and forecasts from CNN Business.A high-level overview of Atai Life Sciences N.V. (ATAI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Get the latest Atai Life Sciences N.V. (ATAI) stock news and headlines to help you in your trading and investing decisions.ATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary. $0.08 (7.69%) Today $1.14 0.02 (1.79%) After Hours About Feed News Earnings Fundamentals There is no chart data available for this period 1d 1w 1m 3m 6m 1y All …On December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until …On December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until …ATAI Life Sciences is a biopharmaceutical company focused on developing psychedelic-based treatments for mental health conditions. The company has a diverse portfolio of drug candidates in various ...Tesla (TSLA): 9.24% portfolio weight. Electric vehicle bellwether Tesla ( TSLA) has been a favourite Cathie Wood’s stock over the years. As of 27 July 2022, Tesla led the top 10 holdings of ARKK with a weight of 9.2%. ARK Invest had extremely bullish views on Tesla in its latest report on the stock published on 14 April 2022.So far this year, Atai has tumbled more than 40% and Compass Pathways has fallen almost 60%. The Horizons Psychedelic Stock Index ETF, which tracks the North American Psychedelics Index , is down ...Creso Pharma and Red Light Holland entered into a definitive scheme implementation deed to combine businesses and create The HighBrid LabATAI Life Sciences is a biopharmaceutical company focused on developing psychedelic-based treatments for mental health conditions. The company has a diverse portfolio of drug candidates in various ...ATAI stock closed at $1.12 and is down -$0.08 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ATAI has a poor overall score of 33 meaning the stock holds a better value than just 33% of stocks at its current price.atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation ...Dec 4, 2023 · ATAI stock closed at $1.12 and is down -$0.08 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ATAI has a poor overall score of 33 meaning the stock holds a better value than just 33% of stocks at its current price. Feb 9, 2023 · 1. ATAI Life Sciences. The financial services firm H.C. Wainwright & Co. recently issued a $20 price target on ATAI Life Sciences (ATAI 7.69%) stock. This 12-month price target implies an upside ... According to 4 analysts, the average rating for ATAI stock is "Strong Buy." The 12-month stock price forecast is $13.5, which is an increase of 1,110.76% from the latest price.Atai Life Sciences Market Cap. Atai Life Sciences has a market cap or net worth of $180.95 million as of November 22, 2023. Its market cap has decreased by - ...Company Description. ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive …Atai stock closed at $17.38 in Friday's trading session. Other coverage included an Outperform from Credit Suisse with a price target of $25; Buy ratings from Citigroup. HOME. MAIL.Webatai Life Sciences has priced its upsized U.S. IPO of 15M common shares (from ~14.3M) at $15.00/share. Expected gross proceeds are $225M. Underwriters' over-allotment is an additional 2.25M shares.WebOver the last 12 months, ATAI Life Sciences's shares have ranged in value from as little as $1.05 up to $3.65. A popular way to gauge a stock's volatility is its "beta". ATAI.US volatility (beta: 0.83) Avg. volatility (beta: 1.00) Low High. Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is ...ATAI stock is down 44% year-to-date (YTD), despite a 10% increase over the past month. Shares are changing hands at 2.4x book value. Wall Street’s 12-month median price forecast for ATAI stock ...Discover historical prices for ATAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Atai Life Sciences N.V. stock was issued. Atai Life Sciences (NASDAQ: ATAI) is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. In the first week of the new year, the stock plummeted when the failed results of ATAI's NYC-based subsidiary, Perception Neuroscience's Phase 2a study of proprietary R-ketamine PCN-101 on patients with ...Mar 6, 2023 · In January, Atai's majority-owned unit Perception Neuroscience's therapy PCN-101 (R-ketamine) did not meet the main goal of a phase 2a trial in treatment-resistant depression which sent the stock ... Atai Life Sciences (NASDAQ: ATAI) Psychedelic stocks have performed about as well as marijuana stocks over the last few months. Given the general uncertainties surrounding the future of recreational legislation, mass adoption from investors hasn’t necessarily been a trend. Nevertheless, that hasn’t stopped some from staking a claim in …Find the latest Braxia Scientific Corp. (BRAXF) stock quote, history, news and other vital information to help you with your stock trading and investing.WebThe Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors. 7 Stocks That AI Predicts Will Soar in 2024 InvestorPlace. Artificial intelligence (AI) has become an invaluable ...ATAI Life Sciences NV’s trailing 12-month revenue is $0.3 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-0.317 per share for the current fiscal year. ATAI Life Sciences NV does not currently pay a dividend.Get the latest Atai Life Sciences N.V. (ATAI) stock news and headlines to help you in your trading and investing decisions.Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. Current and historical return on equity (ROE) values for Atai Life Sciences (ATAI) over the last 10 years. Return on equity can be defined as the amount of net income ...ATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary.Jul 8, 2022 · From July 5 to July 7, the ARK Genomic Revolution ETF purchased 268,974 shares of ATAI Life Sciences (NASDAQ: ATAI). This was the ETF and Ark Invest’s first purchase of ATAI stock since March 14. ATAI Life Sciences N.V. analyst estimates, including ATAI earnings per share estimates and analyst recommendations. Get ATAI Life Sciences BV (ATAI) share price today and stock analysis, price valuation, performance, fundamentals, market cap, shareholding, ...Feb 5, 2023 · ATAI Life Sciences (NASDAQ: ATAI) is another clinical-stage biotech looking to make a mark in the mental health space. Its stock took a dive recently following failed results of its Phase 2a study ... ATAI Life Sciences NV (ATAI) stock has fallen -4% while the S&P 500 has gained 0.75% as of 12:29 PM on Wednesday, Jan 11. ATAI has fallen -$0.07 from the previous closing price of $1.75 on volume of 747,257 shares. Over the past year the S&P 500 is lower by -15.45% while ATAI has fallen -73.67%. ATAI lost -$1.29 per share in the over the last ...Jan 17, 2023 · Atai Life Sciences (NASDAQ: ATAI) is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. In the first week of the new year, the stock plummeted when the failed results of ATAI's NYC-based subsidiary, Perception Neuroscience's Phase 2a study of proprietary R-ketamine PCN-101 on patients with ... ATAI stock closed at $2.19 and is up $0.18 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ATAI has a roughly average overall score of 60 meaning the stock holds a better value than 60% of stocks at its current price.ATAI Life Sciences NV’s trailing 12-month revenue is $0.3 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-0.317 per share for the current fiscal year. ATAI Life Sciences NV does not currently pay a dividend.Atari SA () Stock Market info Recommendations: Buy or sell Atari stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Atari share forecasts, stock quote and buy / sell signals below.According to present data Atari's PONGF shares and potentially its market environment have been in bearish cycle last 12 months (if exists).WebFind the latest Atai Life Sciences N.V. (ATAI) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.The ATAI IPO will raise around $100 million that the company can add to its already sizeable cash on hand, about $97 billion as of the end of 2020. ATAI stock could be the biggest psychedelic ...6.10. +0.12. +2.01%. Psychedelic substances are often grouped together with cannabis, but there are some important distinctions. ATAI, CMPS and FTRP are some of the best stocks in the space.ATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary.MRNA. $ 78.52. 0.45%. Open in Yahoo | Open in Google | Open in Finviz. Find latest ATAI Life Sciences N.V. (ATAI) stock discussions and message board on Twitter, StocksTwits, Reddit, SeekingAlpha and other social media.Atai Life Sciences ( ATAI 2.80%), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of ...Dec 1, 2023 · View atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ATAI Life Sciences NV ( ATAI) is up Wednesday morning, with the stock gaining 1.12% in pre-market trading to 1.8. ATAI's short-term technical score of 12 indicates that the stock has traded less bullishly over the last month than 88% of stocks on the market. In the Biotechnology industry, which ranks 115 out of 146 industries, ATAI ranks higher ...Atai Life Sciences (NASDAQ: ATAI) Psychedelic stocks have performed about as well as marijuana stocks over the last few months. Given the general uncertainties surrounding the future of recreational legislation, mass adoption from investors hasn’t necessarily been a trend. Nevertheless, that hasn’t stopped some from staking a claim in …ATAI Life Sciences Stock (NASDAQ: ATAI) stock price, news, charts, stock research, profile.View atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.It is no secret that for those invested in psychedelic stocks, the last few months have been rough. At the time of writing, over the last 3 months, MindMed (Nasdaq: MNMD, NEO:MMED) is down a whopping 31%, atai Life Sciences (Nasdaq: ATAI) has plummeted 32%, and Compass Pathways (Nasdaq: CMPS) has fallen 19%. The carnage …Atai’s majority-owned subsidiary Perception Neuroscience will launch the first in a series of clinical trials on R-ketamine early this year in the U.S. The first trial will be a drug interaction ...WebATAI Life Sciences NV (ATAI) stock is trading at $1.33 as of 10:11 AM on Friday, Nov 3, an increase of $0.09, or 7.31% from the previous closing price of $1.24. The stock has traded between $1.20 and $1.34 so far today. Volume today is low. So far 138,480 shares have traded compared to average volume of 503,480 shares.Jul 8, 2022 · From July 5 to July 7, the ARK Genomic Revolution ETF purchased 268,974 shares of ATAI Life Sciences (NASDAQ: ATAI). This was the ETF and Ark Invest’s first purchase of ATAI stock since March 14. Atai Life Sciences has a strong pipeline of drugs for the next 18 months, and will pursue aggressive growth. The company had $335 million in cash as of May 2022, which is roughly 50% of its ...atai Life Sciences - ATAI - Stock Price Today - Zacks atai Life Sciences (ATAI) (Delayed Data from NSDQ) $1.09 USD +0.02 (1.87%) Updated Nov 22, 2023 …Find the latest Atai Life Sciences N.V. (ATAI) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.ATAI's current price target is $12.80. Learn why top analysts are making this stock forecast for Atai Life Sciences at MarketBeat.Atai stocks

ATAI. 1.095. +2.34%. Webull offers ATAI Ent Holdg (ATAI) historical stock prices, in-depth market analysis, NASDAQ: ATAI real-time stock quote data, in-depth charts, free ATAI options chain data, and a fully built financial calendar to help you invest smart. Buy ATAI stock at Webull.. Atai stocks

atai stocks

On average, Wall Street analysts predict. that Atai Life Sciences Nv's share price could reach $17.50 by Aug 14, 2024. The average Atai Life Sciences Nv stock price prediction forecasts a potential upside of 1,490.91% from the current ATAI share price of $1.10. Mar 27, 2023 · 0. These 7 analysts have an average price target of $13.29 versus the current price of ATAI Life Sciences at $1.3447, implying upside. Below is a summary of how these 7 analysts rated ATAI Life ... See Full ATAI Report. ATAI stock closed at $1.12 and is down -$0.08 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ATAI has a poor overall score of 33 meaning the stock holds a better value than just 33% of stocks at its current price.Web2023-04-13 15:36:07 ET German biotech Atai Life Sciences ( NASDAQ: ATAI ) added 12% Thursday after announcing investigators have dosed the first.0. Login; Sign Up; Ad. ATAI - Atai spikes 12% as dosing begins in Phase 1 trial for depression candidate. home / stock / atai / atai news. RSS . ATAI ATAI Quote ATAI Short ATAI News ATAI ...WebBasic Membership Access to Journal, Shadow Stock portfolio & monthly updates for stock screens; A+ Investor Full access to AAII.com, Journal, and a power data suite for investment ideas; AAII Platinum Full access to all of AAII's model portfolios and premium services at a significant discountWebPONGF | Complete Atari S.A.S. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.ATAI Life Sciences NV (ATAI) stock is lower by -5.5% while the S&P 500 has risen 0.05% as of 9:55 AM on Thursday, Oct 19. ATAI has fallen -$0.07 from the previous closing price of $1.36 on volume of 137,605 shares. Over the past year the S&P 500 has gained 16.04% while ATAI has fallen -54.42%. ATAI lost -$0.92 per share in the over the last 12 ...$0.08 (7.69%) Today $1.14 0.02 (1.79%) After Hours About Feed News Earnings Fundamentals There is no chart data available for this period 1d 1w 1m 3m 6m 1y All …Mind Medicine Inc. ( MNMD) MindMed shares are down by 38.7% over the past three months, but they are up 23.2% year to date as of Oct. 24. The New York-based company specializes in the development ...Nov 29, 2023 · According to 4 analysts, the average rating for ATAI stock is "Strong Buy." The 12-month stock price forecast is $13.5, which is an increase of 1,110.76% from the latest price. 29 thg 11, 2021 ... Atai Life Sciences, the Peter Thiel-backed psychedelic start-up, has increased its stake in Compass Pathways.atai Life Sciences NV ATAI: ... Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market.WebApr 21, 2023 · ATAI stock closed at $2.19 and is up $0.18 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ATAI has a roughly average overall score of 60 meaning the stock holds a better value than 60% of stocks at its current price. View the latest ATAI Life Sciences N.V. (ATAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.The upgrade of atai Life Sciences N.V. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...atai’s development candidates, such as RL-007 and GRX-917, all represent significant opportunities to address unmet medical needs of patients living with mental health conditionsContinued ...The latest Atari stock prices, stock quotes, news, and PONGF history to help you invest and trade smarter.Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...ATAI stock, a health technology company in the pharmaceutical industry, had a mixed performance on November 21, 2023, according to data from CNN Money. The stock opened at $1.10 and traded within a narrow range of $1.09 to $1.11. The trading volume was relatively low at 18,798 shares. ATAI has a market capitalization of $182.6 million.Data sources: Yahoo! Finance and company websites. Market caps as of Oct. 23, 2023. Company Market Cap Description Atai Life Sciences (NASDAQ:ATAI) $215.8 millionAtai Life Sciences has a strong pipeline of drugs for the next 18 months, and will pursue aggressive growth. The company had $335 million in cash as of May 2022, which is roughly 50% of its ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...A high-level overview of Atai Life Sciences N.V. (ATAI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.A recently published study has found that more than 80% of psychiatrists positively view the use of psychedelic substances in treating a range of mental-health conditions. For the study, researchers from different institutions including Case Western Reserve University, Harvard Medical School and Yale University School of Medicine, sent surveys to an estimated …WebThis stake is worth roughly $98M as of Tuesday, March 28, based on COMPASS Pathways’ closing price of $10.23/share on that day. You can find atai’s filed 10-K from last Friday here. With ...Complete ATAI Life Sciences N.V. stock information by Barron's. View real-time ATAI stock price and news, along with industry-best analysis.According to 6 analyst offering 12-month price targets in the last 3 months, ATAI Life Sciences has an average price target of $15.33 with a high of $23.00 and a low of $9.00. Below is a summary ...atai Life Sciences - ATAI - Stock Price Today - Zacks atai Life Sciences (ATAI) (Delayed Data from NSDQ) $1.09 USD +0.02 (1.87%) Updated Nov 22, 2023 …Discover historical prices for ATAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Atai Life Sciences N.V. stock was issued.The latest Atari stock prices, stock quotes, news, and PONGF history to help you invest and trade smarter. ATAI stock is down 44% year-to-date (YTD), despite a 10% increase over the past month. Shares are changing hands at 2.4x book value. Wall Street’s 12-month median price forecast for ATAI stock ...TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comWebThe ATAI stock price is closed at $ 1.120000 with a total market cap valuation of $ 185.93M (166.01M shares outstanding). The ATAI is trading on NASDAQ with the ...Clinical-stage psychedelics company atai Life Sciences (NASDAQ: ATAI) reported its financial results and corporate updates for the third quarter ended September 30, 2023. In numbers:Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide brokerage services.The Atai Life Sciences N.V. stock forecast for tomorrow is $ 1.095019, which would represent a -2.23% loss compared to the current price. In the next week, the ...In 2019 ATAI had a net loss of $24,384,000. They had basically no income (as would be expected from any nascent company developing new drugs). Roughly $3 million was spent on R&D, almost $10 million on acquiring programs, and $5 million on general/administrative expenses. In 2020 ATAI has a net loss of $178,000,000.The subreddit to share, discuss and enjoy the Stock journey of Atari SA. The creator of all time classics like Pong & Space Invaders on their way to celebrate 50 years of spreading joy! - A place to share news, stories and discuss everything related to the ATA and PONGF stock. Please keep in mind that Stock and Token posts can contain 100% ...Creso Pharma and Red Light Holland entered into a definitive scheme implementation deed to combine businesses and create The HighBrid LabThe subreddit to share, discuss and enjoy the Stock journey of Atari SA. The creator of all time classics like Pong & Space Invaders on their way to celebrate 50 years of spreading joy! - A place to share news, stories and discuss everything related to the ATA and PONGF stock. Please keep in mind that Stock and Token posts can contain 100% ...Florian Brand's Atai Life Sciences went public three years after launching, fueled by Silicon Valley interest and promising science, but it's still waiting for its first big breakthrough.After declining more than 62% over the past six months, ATAI stock needs a positive catalyst to turn things around. This is likely part of the reason behind the Atai layoffs, which follow the company’s promise to implement a “company-wide cost optimization” initiative, a measure that hasn’t yet yielded the intended results.WebP/E & PEG Ratios. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a ...ATARI stock information. ATARI is a company listed and traded on the London Stock Exchange under ALATA.PAR.As of 30-11-2023, the stock price stands at 0.11 EUR.The market has seen -0.00 EUR change, representing -3.3333% change from the previous close of 0.11 EUR. ALATA.PAR stock opened at 0.12 EUR, reached a high of 0.12 EUR, and a …WebThe stock has given up three-quarters of its market value year to date. Ark Genomic bought 67,384 shares of Atai Life Sciences - Get Free Report, valued at $284,360. Atai is a Berlin ...377.43. -0.11%. 9.38M. View today's Atari stock price and latest ALATA news and analysis. Create real-time notifications to follow any changes in the live stock price.WebATAI Life Sciences is a biopharmaceutical company focused on developing psychedelic-based treatments for mental health conditions. The company has a diverse portfolio of drug candidates in various ...Dec 1, 2023 · View atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Atai already has an MDMA-derived drug in its pipeline, EMP-01, in collaboration with Empath Bio. If the FDA approves MDMA, it will help Atai as it will further interest and investments into the ...Shares of the Peter Thiel -backed psychedelic start-up Atai Life Sciences jumped Friday on their first day of trading on Wall Street. The newly listed Nasdaq stock opened up 40% before pulling ...atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation ...Florian Brand's Atai Life Sciences went public three years after launching, fueled by Silicon Valley interest and promising science, but it's still waiting for its first big breakthrough.Real time Atai Life Sciences (ATAI) stock price quote, stock graph, news & analysis.With its shares down by 60% in the last 12 months and a recent layoff affecting 30% of its workforce, it's fair to say that Atai Life Sciences ( ATAI 1.87%) is having a rough go of things lately ...Atai Life Sciences ( ATAI 2.80%), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of ...Sep 1, 2023 · Atai Life Sciences has a strong financial position with $227.5 million in cash and funding to support its operations into the 1st half of 2026. The global schizophrenia drug market is expected to ... atai Life Sciences - ATAI - Stock Price Today - Zacks atai Life Sciences (ATAI) (Delayed Data from NSDQ) $1.09 USD +0.02 (1.87%) Updated Nov 22, 2023 …In May 2021, Atai purchased additional preferred stock of Neuronasal. As of the date, the company now holds a 56.5% equity ownership position in Neuronasal – a company focused on treating concussions and other forms of …. Nvda dividend date 2023